Valproic Acid Solution
Product Images NDC 0121-1350

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valproic Acid (NDC 0121-1350). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Valproic 01)

Chemical structure of valproic acid showing carbon, hydrogen, and oxygen atoms with their respective bonds indicating the arrangement of the molecule's functional groups.*

FDA Label Image

Figure 1 (Valproic 02)

A cumulative distribution plot comparing the percent reduction in CPS (complex partial seizure) rate between Divalproex Sodium and Placebo groups. The x-axis represents the percentage of patients, and the y-axis shows the percent reduction in CPS rate, with improvement above zero and worsening below zero. Solid and dashed lines depict Divalproex Sodium and Placebo effects, respectively.*

FDA Label Image

Figure 2 (Valproic 03)

A line graph showing the percentage reduction in CPS rate among patients receiving high dose versus low dose treatment. The y-axis represents improvement or worsening in CPS rate as a percentage, while the x-axis shows the percentage of patients. Two curves compare the outcomes for high dose (solid line) and low dose (dashed line) groups.*

FDA Label Image

Principal Display Panel (473 mL Bottle Label)

Valproic Acid Oral Solution USP 250 mg/5 mL label shows 16 fl oz (473 mL) bottle size. The label includes dosage strength, pharmacist dispensing instruction, storage information, and the labeler PAI Pharmaceutical Associates, Inc., Greenville, SC. It is an oral solution prescription drug.*

FDA Label Image

Principal Display Panel (10 mL Cup Label)

Label for Valproic Acid Oral Solution USP, 500 mg/10 mL strength. The label indicates a 10 mL delivery volume, includes the NDC 0121-1350-10, and shows it is a non-child-resistant package. The labeler is Pharmaceutical Associates, Inc., Greenville, SC.*

FDA Label Image

Principal Display Panel (5 mL Cup Label)

VALPROIC ACID oral solution USP 250 mg/5 mL label showing dispensing instructions with NDC 0121-4675-05. The label indicates a 5 mL dose delivery and notes the package is not child-resistant. It also displays the labeler as Pharmaceutical Associates, Inc., Greenville, SC, and includes a barcode.*

FDA Label Image

Valproic 07

Label for Valproic Acid Oral Solution USP 250 mg/5 mL, an oral solution prescription drug. The label indicates each 5 mL contains equivalent of 250 mg valproic acid as the sodium salt. It specifies a 16 fl oz (473 mL) container and is labeled for pharmacist dispensing with an attached Medication Guide. The product is manufactured by PAI Pharmaceutical Associates, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.